Experimental drug enters human testing for Tough-to-Treat cancers
Disease control
Recruiting now
This is the first human trial of an experimental cancer drug called DM005. The study aims to find a safe and effective dose for patients with advanced solid tumors like lung and head/neck cancer that have stopped responding to standard treatments. Researchers will give the drug t…
Phase: PHASE1 • Sponsor: Doma Biopharmaceutical（Suzhou）Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC